Bio-Rad Laboratories, Inc. BIO.B Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Clinical Diagnostics | $363.6M-14.5% | $425.3M+8.7% | $391.2M+0.6% | $388.8M+9.0% | $356.8M-9.1% | |
| Life Science | $228.5M-14.7% | $267.9M+2.3% | $261.8M-0.4% | $262.8M+15.0% | $228.6M-16.9% | |
| Net Sales by Geography | ||||||
| Americas | $45.1M+0.9% | $44.7M+12.3% | $39.8M-3.2% | $41.1M+3.3% | $39.8M-3.6% | |
| Asia Pacific | $110.4M-31.8% | $161.8M+33.7% | $121M-4.3% | $126.4M+21.4% | $104.1M-28.9% | |
| Europe | $206.8M-14.8% | $242.6M+9.2% | $222.2M+2.3% | $217.2M+8.7% | $199.8M-9.9% | |
| UNITED STATES | $229.8M-5.9% | $244.1M-9.6% | $270M+1.2% | $266.9M+10.4% | $241.7M-6.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bio-Rad Laboratories, Inc. break its business down?
- Bio-Rad Laboratories, Inc. (BIO.B) reports net sales by business across 3 parts — All Other Segments, Clinical Diagnostics and Life Science. Each is extracted from the segment footnotes and tracked over time.
- Where does Bio-Rad Laboratories, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bio-Rad Laboratories, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
